How can community pharmacy teams prevent prescription and over-the-counter opioid misuse in North East England? A qualitative study using the Capability, Opportunity and Motivation Behaviour (COM-B) modelOgochukwu Fidelia Offu, Daniel Okeowo, Shelina Visram, Adam Pattison Rathbone, Laura Lindsey
12 May 2025
Acupuncture for substance use disorders: a protocol of systematic review and meta-analysis of randomised controlled trialsChao-ren Tan, Meng Qiao, JIN CHANG, Shu-Min Chen, Yingying Wang
3 April 2025
Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelinesMd. Belal Hossain, Brenda Carolina Guerra-Alejos, Megan Kurz, Jeong Eun Min, Mohammad Ehsanul Karim, Shaun Seaman, Paxton Bach, Robert W Platt, Paul Gustafson, Julie Bruneau, Lawrence McCandless, Maria Eugenia Socías, Bohdan Nosyk
5 March 2025
Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorderCatharine Montgomery, Yasir Abbasi, Devon De Silva, Rosalind Gittins, Andrew Jones, Marie-Claire Van Hout
18 February 2025
Supervised Injecting Room Cohort Study (SIRX): study protocolAshleigh C Stewart, Matthew Hickman, Paul A Agius, Nick Scott, Jack Stone, Amanda Roxburgh, Daniel O’Keefe, Peter Higgs, Thomas Kerr, Mark A Stoové, Alexander Thompson, Sione Crawford, Josephine Norman, Dylan Vella-Horne, Zachary LloydSee the full list of authors
11 February 2025
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotheray for methamphetamine use disorder (the KAPPA trial)Kathryn Fletcher, Nadine Ezard, Krista J Siefried, Harriet MacDonald, Liam Acheson, Gillinder Bedi, Alexandre Guerin, Elizabeth Knock, Michael Millard, Robert May, Jonathan Brett, Jess Doumany, Celia Morgan, Brendan Clifford
10 February 2025
Trial protocol of an open-label pilot study of oral ltrexone–propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)Krista J Siefried, Liam Acheson, Brendan Clifford, Carl Moller, Jonathan Brett, Michael Christmass, Adrian John Dunlop, Paul S Haber, Didier Jutras-Aswad, Nicholas Lintzeris, Kirsten Morley, Steven Shoptaw, Madhukar H Trivedi, Nadine Ezard
7 February 2025
Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction servicesKimia Ziafat, Lisa Liu, Bradley Kievit, Kristi Papamihali, Brittany Graham, Michael Otterstatter, Jane A Buxton
15 January 2025
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)Mette Kruse Klausen, Tugba Kuzey, Julie Niemann Pedersen, Signe Keller Justesen, Line Rasmussen, Ulla B Knorr, Graeme Mason, Claus Thorn Ekstrøm, Jens Juul Holst, George Koob, Helene Benveniste, Nora D Volkow, Gitte M Knudsen, Tina Vilsbøll, Anders Fink-Jensen
8 January 2025
Challenges of smoking cessation in users of non-invasive stimulation technologies in Iran: a parallel convergent mixed-methods studyMohammad Hasan Sahebihagh, Mina Hosseinzadeh, Mojgan Mirghafourvand, Parvin Sarbakhsh, Hossein Nemati
26 December 2024